Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Xin ChengYucheng CaoXiaowei WangLin ChengYaqiong LiuJun LeiWei-Jun PengDazun ShiPublished in: Journal of immunology research (2022)
KLRB1 may be a prognostic and immunological biomarker across tumors. At the same time, KLRB1 expression can reflect the sensitivity of cancer patients to chemotherapy drugs. KLRB1 may become a new target for immunotherapy.